gamer456148

Decent Dip Entry for CAPR: Buy Alert!

看多
NASDAQ:CAPR   Capricor Therapeutics, Inc.
Right now, I am confident enough to say that CAPR is due for a likely reentry. I believe that it has been recently oversold and the bearish correlation is about to have its resistance popped quite soon. The upswing potential is there. That being said, please proceed with caution and invest at your own risk. As always, everything I say is on an opinion based basis not meant to be taken seriously as actionable financial advice. Do your own due diligence.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。